Share Price and Basic Stock Data
Last Updated: October 18, 2025, 7:07 pm
| PEG Ratio | -2.63 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Vinyl Chemicals (I) Ltd operates within the chemical sector, focusing on the production of vinyl-based products. As of March 2025, the company reported sales of ₹625 Cr, reflecting a growth trajectory from ₹597 Cr in the previous year. However, sales have shown volatility in the recent quarters, with a notable decline in the December 2023 quarter, where sales were ₹159.03 Cr, followed by a recovery to ₹168.27 Cr in March 2024. The company’s operating profit margin (OPM) stood at 4.88% for the fiscal year ending March 2025, a slight decrease from 4.99% in the previous year, indicating challenges in cost management. The cash conversion cycle (CCC) for the company is reported at 23 days, suggesting efficient management of working capital, especially considering the industry norm typically hovers around 30-45 days. Overall, while Vinyl Chemicals has experienced fluctuations in sales, its ability to maintain a relatively low CCC can be seen as a positive factor in its operational efficiency.
Profitability and Efficiency Metrics
The profitability metrics for Vinyl Chemicals demonstrate a mixed performance. The company’s net profit for the fiscal year 2025 recorded at ₹22 Cr, consistent with the previous year’s net profit of ₹22 Cr, indicating stability albeit at a lower profit level compared to ₹36 Cr in fiscal 2023. The return on equity (ROE) for the company stood at 17.62%, which is relatively robust, suggesting efficient use of equity capital. However, the return on capital employed (ROCE) has declined to 23.89% from 25.29% in the prior year, indicating a slight decrease in capital efficiency. The interest coverage ratio (ICR) is exceptionally high at 606.02x, reflecting no reliance on debt, which is a significant strength. While the operating profit margin has fluctuated, the overall profitability metrics indicate a stable but cautious approach in a potentially challenging market environment.
Balance Sheet Strength and Financial Ratios
Vinyl Chemicals boasts a strong balance sheet characterized by zero borrowings, which positions the company favorably in terms of debt management. As of March 2025, total reserves reached ₹125 Cr, up from ₹115 Cr in the previous year, indicating a healthy accumulation of retained earnings. The company’s current ratio stands at 1.93, suggesting good short-term liquidity, while the quick ratio of 1.46 indicates sufficient ability to meet immediate liabilities. The price-to-book value (P/BV) ratio is reported at 4.09x, which may be perceived as high compared to typical industry standards, reflecting investor confidence in the company’s growth potential. Furthermore, the asset turnover ratio of 2.20% indicates effective utilization of assets to generate revenue. The financial ratios reflect a firm with a solid capital structure and prudent financial management, though the elevated P/BV could warrant scrutiny from value-oriented investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Vinyl Chemicals exhibits a strong promoter holding of 50.42%, which signals a commitment from the management. However, foreign institutional investors (FIIs) have decreased their presence significantly, holding 0.00% as of March 2025, compared to 1.39% in September 2022, which may raise concerns about external investor confidence. Domestic institutional investors (DIIs) hold a minimal share of 0.02%, indicating limited institutional interest. The public shareholding stands at 49.57%, with a total of 41,227 shareholders, suggesting a broad shareholder base. This distribution reflects a predominantly retail investor interest, which can be both a strength and a risk, as retail investors may be more susceptible to market volatility. The decline in institutional support could pose challenges in times of market uncertainty, making it crucial for the management to enhance engagement with institutional investors.
Outlook, Risks, and Final Insight
If margins sustain and operational efficiencies are maintained, Vinyl Chemicals could leverage its strong balance sheet to capitalize on growth opportunities in the chemical sector. However, the risks remain palpable, particularly related to market fluctuations that could impact sales and profitability. The decline in institutional investor participation may also hinder capital-raising efforts in the future. Additionally, the company must address the volatility in its sales and operating margins to maintain investor confidence. If the management can enhance operational efficiencies and stabilize sales trends, the company may improve its profitability metrics and attract renewed interest from institutional investors. Continuous monitoring of industry trends and effective cost management will be essential in navigating potential headwinds in the market.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Vinyl Chemicals (I) Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Metallic Coal & Coke Ltd | 5.94 Cr. | 30.0 | / | 77.6 | 0.00 % | 0.37 % | 2.00 % | 100 | |
| Gensol Engineering Ltd | 144 Cr. | 37.5 | 869/31.9 | 1.40 | 155 | 0.00 % | 14.3 % | 22.4 % | 10.0 |
| Fusion Micro Finance Ltd | 2,461 Cr. | 183 | 227/124 | 101 | 0.00 % | 2.96 % | 54.5 % | 10.0 | |
| Five X Tradecom Ltd | 0.99 Cr. | 0.48 | / | 9.35 | 0.00 % | 0.00 % | 0.00 % | 10.0 | |
| East West Holdings Ltd | 51.5 Cr. | 4.04 | 8.90/3.97 | 5.12 | 0.00 % | 6.98 % | 0.86 % | 2.00 | |
| Industry Average | 7,488.43 Cr | 260.27 | 357.46 | 100.76 | 0.22% | 11.73% | 22.92% | 9.18 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 310.75 | 324.17 | 270.66 | 106.93 | 115.31 | 154.40 | 159.03 | 168.27 | 155.63 | 150.34 | 146.40 | 172.88 | 151.23 |
| Expenses | 301.06 | 311.30 | 260.62 | 97.41 | 111.87 | 149.87 | 150.28 | 159.63 | 149.65 | 144.39 | 142.74 | 162.93 | 149.26 |
| Operating Profit | 9.69 | 12.87 | 10.04 | 9.52 | 3.44 | 4.53 | 8.75 | 8.64 | 5.98 | 5.95 | 3.66 | 9.95 | 1.97 |
| OPM % | 3.12% | 3.97% | 3.71% | 8.90% | 2.98% | 2.93% | 5.50% | 5.13% | 3.84% | 3.96% | 2.50% | 5.76% | 1.30% |
| Other Income | 5.00 | 0.70 | 0.16 | 0.99 | 1.26 | 0.82 | 0.64 | 1.73 | 0.78 | 1.05 | 2.99 | 0.19 | 4.09 |
| Interest | 0.09 | 0.15 | 0.17 | 0.94 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
| Depreciation | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 |
| Profit before tax | 14.58 | 13.39 | 10.01 | 9.54 | 4.66 | 5.31 | 9.36 | 10.33 | 6.73 | 6.95 | 6.61 | 10.11 | 6.02 |
| Tax % | 25.10% | 24.94% | 26.37% | 23.48% | 24.89% | 26.93% | 25.96% | 27.11% | 26.89% | 26.19% | 24.21% | 28.09% | 26.08% |
| Net Profit | 10.92 | 10.05 | 7.37 | 7.30 | 3.50 | 3.88 | 6.93 | 7.53 | 4.92 | 5.13 | 5.01 | 7.27 | 4.45 |
| EPS in Rs | 5.96 | 5.48 | 4.02 | 3.98 | 1.91 | 2.12 | 3.78 | 4.11 | 2.68 | 2.80 | 2.73 | 3.96 | 2.43 |
Last Updated: August 1, 2025, 9:25 am
Below is a detailed analysis of the quarterly data for Vinyl Chemicals (I) Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 151.23 Cr.. The value appears to be declining and may need further review. It has decreased from 172.88 Cr. (Mar 2025) to 151.23 Cr., marking a decrease of 21.65 Cr..
- For Expenses, as of Jun 2025, the value is 149.26 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 162.93 Cr. (Mar 2025) to 149.26 Cr., marking a decrease of 13.67 Cr..
- For Operating Profit, as of Jun 2025, the value is 1.97 Cr.. The value appears to be declining and may need further review. It has decreased from 9.95 Cr. (Mar 2025) to 1.97 Cr., marking a decrease of 7.98 Cr..
- For OPM %, as of Jun 2025, the value is 1.30%. The value appears to be declining and may need further review. It has decreased from 5.76% (Mar 2025) to 1.30%, marking a decrease of 4.46%.
- For Other Income, as of Jun 2025, the value is 4.09 Cr.. The value appears strong and on an upward trend. It has increased from 0.19 Cr. (Mar 2025) to 4.09 Cr., marking an increase of 3.90 Cr..
- For Interest, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
- For Depreciation, as of Jun 2025, the value is 0.03 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.02 Cr. (Mar 2025) to 0.03 Cr., marking an increase of 0.01 Cr..
- For Profit before tax, as of Jun 2025, the value is 6.02 Cr.. The value appears to be declining and may need further review. It has decreased from 10.11 Cr. (Mar 2025) to 6.02 Cr., marking a decrease of 4.09 Cr..
- For Tax %, as of Jun 2025, the value is 26.08%. The value appears to be improving (decreasing) as expected. It has decreased from 28.09% (Mar 2025) to 26.08%, marking a decrease of 2.01%.
- For Net Profit, as of Jun 2025, the value is 4.45 Cr.. The value appears to be declining and may need further review. It has decreased from 7.27 Cr. (Mar 2025) to 4.45 Cr., marking a decrease of 2.82 Cr..
- For EPS in Rs, as of Jun 2025, the value is 2.43. The value appears to be declining and may need further review. It has decreased from 3.96 (Mar 2025) to 2.43, marking a decrease of 1.53.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:10 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 293 | 442 | 335 | 293 | 375 | 483 | 372 | 404 | 865 | 1,013 | 597 | 625 | 621 |
| Expenses | 282 | 424 | 326 | 283 | 361 | 469 | 366 | 389 | 821 | 966 | 572 | 600 | 599 |
| Operating Profit | 10 | 18 | 9 | 9 | 14 | 14 | 6 | 15 | 44 | 47 | 25 | 26 | 22 |
| OPM % | 4% | 4% | 3% | 3% | 4% | 3% | 2% | 4% | 5% | 5% | 4% | 4% | 3% |
| Other Income | 1 | 1 | 3 | 4 | 4 | 1 | 4 | 0 | 2 | 2 | 4 | 5 | 8 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 11 | 19 | 12 | 13 | 18 | 14 | 10 | 15 | 47 | 48 | 30 | 30 | 30 |
| Tax % | 34% | 34% | 35% | 35% | 36% | 37% | 25% | 26% | 25% | 25% | 26% | 27% | |
| Net Profit | 7 | 12 | 8 | 9 | 12 | 9 | 7 | 11 | 35 | 36 | 22 | 22 | 22 |
| EPS in Rs | 4.08 | 6.73 | 4.36 | 4.76 | 6.36 | 4.83 | 4.07 | 6.19 | 19.01 | 19.44 | 11.91 | 12.18 | 11.92 |
| Dividend Payout % | 24% | 22% | 34% | 38% | 38% | 50% | 59% | 60% | 52% | 51% | 57% | 57% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 71.43% | -33.33% | 12.50% | 33.33% | -25.00% | -22.22% | 57.14% | 218.18% | 2.86% | -38.89% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -104.76% | 45.83% | 20.83% | -58.33% | 2.78% | 79.37% | 161.04% | -215.32% | -41.75% | 38.89% |
Vinyl Chemicals (I) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 11% |
| 3 Years: | -10% |
| TTM: | -3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 24% |
| 3 Years: | -17% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 25% |
| 3 Years: | -18% |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 24% |
| 3 Years: | 21% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 1:51 pm
Balance Sheet
Last Updated: September 10, 2025, 2:48 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Reserves | 24 | 33 | 41 | 46 | 54 | 57 | 59 | 66 | 94 | 111 | 115 | 125 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Other Liabilities | 80 | 69 | 80 | 56 | 115 | 84 | 94 | 200 | 65 | 62 | 188 | 135 |
| Total Liabilities | 106 | 104 | 123 | 104 | 171 | 144 | 156 | 269 | 162 | 176 | 305 | 262 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 5 | 9 | 45 | 39 | 34 | 2 | 47 | 55 | 78 | 40 | 57 | 68 |
| Other Assets | 100 | 95 | 78 | 66 | 137 | 141 | 108 | 214 | 84 | 135 | 247 | 193 |
| Total Assets | 106 | 104 | 123 | 104 | 171 | 144 | 156 | 269 | 162 | 176 | 305 | 262 |
Below is a detailed analysis of the balance sheet data for Vinyl Chemicals (I) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
- For Reserves, as of Mar 2025, the value is 125.00 Cr.. The value appears strong and on an upward trend. It has increased from 115.00 Cr. (Mar 2024) to 125.00 Cr., marking an increase of 10.00 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 135.00 Cr.. The value appears to be improving (decreasing). It has decreased from 188.00 Cr. (Mar 2024) to 135.00 Cr., marking a decrease of 53.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 262.00 Cr.. The value appears to be improving (decreasing). It has decreased from 305.00 Cr. (Mar 2024) to 262.00 Cr., marking a decrease of 43.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 68.00 Cr.. The value appears strong and on an upward trend. It has increased from 57.00 Cr. (Mar 2024) to 68.00 Cr., marking an increase of 11.00 Cr..
- For Other Assets, as of Mar 2025, the value is 193.00 Cr.. The value appears to be declining and may need further review. It has decreased from 247.00 Cr. (Mar 2024) to 193.00 Cr., marking a decrease of 54.00 Cr..
- For Total Assets, as of Mar 2025, the value is 262.00 Cr.. The value appears to be declining and may need further review. It has decreased from 305.00 Cr. (Mar 2024) to 262.00 Cr., marking a decrease of 43.00 Cr..
Notably, the Reserves (125.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 10.00 | 18.00 | 9.00 | 9.00 | 14.00 | 14.00 | 6.00 | 15.00 | 43.00 | 47.00 | 25.00 | 26.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 66 | 40 | 54 | 57 | 75 | 48 | 45 | 100 | 5 | 11 | 65 | 61 |
| Inventory Days | 48 | 33 | 29 | 23 | 57 | 53 | 50 | 70 | 24 | 33 | 78 | 39 |
| Days Payable | 99 | 53 | 88 | 69 | 116 | 63 | 95 | 188 | 26 | 22 | 118 | 78 |
| Cash Conversion Cycle | 15 | 20 | -5 | 11 | 17 | 39 | -1 | -17 | 3 | 22 | 25 | 23 |
| Working Capital Days | 16 | 19 | -4 | 10 | 19 | 36 | 2 | 2 | 7 | 26 | 32 | 27 |
| ROCE % | 45% | 57% | 24% | 21% | 30% | 24% | 14% | 23% | 55% | 44% | 22% | 21% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 12.17 | 11.91 | 19.44 | 19.01 | 6.19 |
| Diluted EPS (Rs.) | 12.17 | 11.91 | 19.44 | 19.01 | 6.19 |
| Cash EPS (Rs.) | 12.23 | 11.96 | 19.49 | 19.01 | 6.19 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 69.05 | 63.66 | 61.77 | 52.35 | 37.12 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 69.05 | 63.66 | 61.77 | 52.35 | 37.12 |
| Dividend / Share (Rs.) | 7.00 | 6.75 | 10.00 | 10.00 | 3.75 |
| Revenue From Operations / Share (Rs.) | 340.85 | 325.45 | 551.96 | 471.58 | 220.32 |
| PBDIT / Share (Rs.) | 16.65 | 16.25 | 26.70 | 25.54 | 8.34 |
| PBIT / Share (Rs.) | 16.59 | 16.20 | 26.64 | 25.54 | 8.34 |
| PBT / Share (Rs.) | 16.57 | 16.17 | 25.91 | 25.45 | 8.31 |
| Net Profit / Share (Rs.) | 12.17 | 11.91 | 19.43 | 19.01 | 6.19 |
| PBDIT Margin (%) | 4.88 | 4.99 | 4.83 | 5.41 | 3.78 |
| PBIT Margin (%) | 4.86 | 4.97 | 4.82 | 5.41 | 3.78 |
| PBT Margin (%) | 4.86 | 4.96 | 4.69 | 5.39 | 3.77 |
| Net Profit Margin (%) | 3.57 | 3.65 | 3.52 | 4.03 | 2.80 |
| Return on Networth / Equity (%) | 17.63 | 18.70 | 31.45 | 36.30 | 16.67 |
| Return on Capital Employeed (%) | 23.89 | 25.29 | 42.84 | 48.43 | 22.12 |
| Return On Assets (%) | 8.51 | 7.15 | 20.29 | 21.56 | 4.22 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 2.20 | 2.48 | 6.00 | 4.02 | 1.90 |
| Current Ratio (X) | 1.93 | 1.62 | 2.83 | 2.47 | 1.34 |
| Quick Ratio (X) | 1.46 | 0.97 | 1.46 | 1.66 | 0.97 |
| Dividend Payout Ratio (NP) (%) | 55.42 | 83.94 | 51.44 | 19.72 | 38.76 |
| Dividend Payout Ratio (CP) (%) | 55.17 | 83.55 | 51.29 | 19.72 | 38.74 |
| Earning Retention Ratio (%) | 44.58 | 16.06 | 48.56 | 80.28 | 61.24 |
| Cash Earning Retention Ratio (%) | 44.83 | 16.45 | 48.71 | 80.28 | 61.26 |
| Interest Coverage Ratio (X) | 763.53 | 611.00 | 36.23 | 283.98 | 329.54 |
| Interest Coverage Ratio (Post Tax) (X) | 559.34 | 448.62 | 27.37 | 212.29 | 245.55 |
| Enterprise Value (Cr.) | 507.69 | 574.53 | 612.80 | 480.31 | 201.52 |
| EV / Net Operating Revenue (X) | 0.81 | 0.96 | 0.60 | 0.55 | 0.49 |
| EV / EBITDA (X) | 16.62 | 19.27 | 12.51 | 10.25 | 13.17 |
| MarketCap / Net Operating Revenue (X) | 0.82 | 0.97 | 0.60 | 0.55 | 0.52 |
| Retention Ratios (%) | 44.57 | 16.05 | 48.55 | 80.27 | 61.23 |
| Price / BV (X) | 4.10 | 4.97 | 5.42 | 5.01 | 3.13 |
| Price / Net Operating Revenue (X) | 0.82 | 0.97 | 0.60 | 0.55 | 0.52 |
| EarningsYield | 0.04 | 0.03 | 0.05 | 0.07 | 0.05 |
After reviewing the key financial ratios for Vinyl Chemicals (I) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For Cash EPS (Rs.), as of Mar 25, the value is 12.23. This value is within the healthy range. It has increased from 11.96 (Mar 24) to 12.23, marking an increase of 0.27.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 69.05. It has increased from 63.66 (Mar 24) to 69.05, marking an increase of 5.39.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 69.05. It has increased from 63.66 (Mar 24) to 69.05, marking an increase of 5.39.
- For Dividend / Share (Rs.), as of Mar 25, the value is 7.00. This value exceeds the healthy maximum of 3. It has increased from 6.75 (Mar 24) to 7.00, marking an increase of 0.25.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 340.85. It has increased from 325.45 (Mar 24) to 340.85, marking an increase of 15.40.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.65. This value is within the healthy range. It has increased from 16.25 (Mar 24) to 16.65, marking an increase of 0.40.
- For PBIT / Share (Rs.), as of Mar 25, the value is 16.59. This value is within the healthy range. It has increased from 16.20 (Mar 24) to 16.59, marking an increase of 0.39.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.57. This value is within the healthy range. It has increased from 16.17 (Mar 24) to 16.57, marking an increase of 0.40.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.17. This value is within the healthy range. It has increased from 11.91 (Mar 24) to 12.17, marking an increase of 0.26.
- For PBDIT Margin (%), as of Mar 25, the value is 4.88. This value is below the healthy minimum of 10. It has decreased from 4.99 (Mar 24) to 4.88, marking a decrease of 0.11.
- For PBIT Margin (%), as of Mar 25, the value is 4.86. This value is below the healthy minimum of 10. It has decreased from 4.97 (Mar 24) to 4.86, marking a decrease of 0.11.
- For PBT Margin (%), as of Mar 25, the value is 4.86. This value is below the healthy minimum of 10. It has decreased from 4.96 (Mar 24) to 4.86, marking a decrease of 0.10.
- For Net Profit Margin (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 5. It has decreased from 3.65 (Mar 24) to 3.57, marking a decrease of 0.08.
- For Return on Networth / Equity (%), as of Mar 25, the value is 17.63. This value is within the healthy range. It has decreased from 18.70 (Mar 24) to 17.63, marking a decrease of 1.07.
- For Return on Capital Employeed (%), as of Mar 25, the value is 23.89. This value is within the healthy range. It has decreased from 25.29 (Mar 24) to 23.89, marking a decrease of 1.40.
- For Return On Assets (%), as of Mar 25, the value is 8.51. This value is within the healthy range. It has increased from 7.15 (Mar 24) to 8.51, marking an increase of 1.36.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.20. It has decreased from 2.48 (Mar 24) to 2.20, marking a decrease of 0.28.
- For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.62 (Mar 24) to 1.93, marking an increase of 0.31.
- For Quick Ratio (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.46, marking an increase of 0.49.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 55.42. This value exceeds the healthy maximum of 50. It has decreased from 83.94 (Mar 24) to 55.42, marking a decrease of 28.52.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 55.17. This value exceeds the healthy maximum of 50. It has decreased from 83.55 (Mar 24) to 55.17, marking a decrease of 28.38.
- For Earning Retention Ratio (%), as of Mar 25, the value is 44.58. This value is within the healthy range. It has increased from 16.06 (Mar 24) to 44.58, marking an increase of 28.52.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 44.83. This value is within the healthy range. It has increased from 16.45 (Mar 24) to 44.83, marking an increase of 28.38.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 763.53. This value is within the healthy range. It has increased from 611.00 (Mar 24) to 763.53, marking an increase of 152.53.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 559.34. This value is within the healthy range. It has increased from 448.62 (Mar 24) to 559.34, marking an increase of 110.72.
- For Enterprise Value (Cr.), as of Mar 25, the value is 507.69. It has decreased from 574.53 (Mar 24) to 507.69, marking a decrease of 66.84.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 0.96 (Mar 24) to 0.81, marking a decrease of 0.15.
- For EV / EBITDA (X), as of Mar 25, the value is 16.62. This value exceeds the healthy maximum of 15. It has decreased from 19.27 (Mar 24) to 16.62, marking a decrease of 2.65.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.82, marking a decrease of 0.15.
- For Retention Ratios (%), as of Mar 25, the value is 44.57. This value is within the healthy range. It has increased from 16.05 (Mar 24) to 44.57, marking an increase of 28.52.
- For Price / BV (X), as of Mar 25, the value is 4.10. This value exceeds the healthy maximum of 3. It has decreased from 4.97 (Mar 24) to 4.10, marking a decrease of 0.87.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.82. This value is below the healthy minimum of 1. It has decreased from 0.97 (Mar 24) to 0.82, marking a decrease of 0.15.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vinyl Chemicals (I) Ltd:
- Net Profit Margin: 3.57%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 23.89% (Industry Average ROCE: 11.73%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 17.63% (Industry Average ROE: 22.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 559.34
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.46
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 23.4 (Industry average Stock P/E: 357.46)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 3.57%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | Regent Chambers, 7th Floor, Mumbai Maharashtra 400021 | cs.vinylchemicals@pidilite.com http://www.vinylchemicals.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. M B Parekh | Chairman & Managing Director |
| Mr. N K Parekh | Director |
| Mr. A B Parekh | Director |
| Mr. P D Shah | Director |
| Mr. L Viswanathan | Director |
| Mrs. Shailashri Bhaskar | Director |
FAQ
What is the intrinsic value of Vinyl Chemicals (I) Ltd?
Vinyl Chemicals (I) Ltd's intrinsic value (as of 18 October 2025) is 206.86 which is 25.59% lower the current market price of 278.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 511 Cr. market cap, FY2025-2026 high/low of 430/215, reserves of ₹125 Cr, and liabilities of 262 Cr.
What is the Market Cap of Vinyl Chemicals (I) Ltd?
The Market Cap of Vinyl Chemicals (I) Ltd is 511 Cr..
What is the current Stock Price of Vinyl Chemicals (I) Ltd as on 18 October 2025?
The current stock price of Vinyl Chemicals (I) Ltd as on 18 October 2025 is 278.
What is the High / Low of Vinyl Chemicals (I) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vinyl Chemicals (I) Ltd stocks is 430/215.
What is the Stock P/E of Vinyl Chemicals (I) Ltd?
The Stock P/E of Vinyl Chemicals (I) Ltd is 23.4.
What is the Book Value of Vinyl Chemicals (I) Ltd?
The Book Value of Vinyl Chemicals (I) Ltd is 69.1.
What is the Dividend Yield of Vinyl Chemicals (I) Ltd?
The Dividend Yield of Vinyl Chemicals (I) Ltd is 2.51 %.
What is the ROCE of Vinyl Chemicals (I) Ltd?
The ROCE of Vinyl Chemicals (I) Ltd is 21.1 %.
What is the ROE of Vinyl Chemicals (I) Ltd?
The ROE of Vinyl Chemicals (I) Ltd is 15.6 %.
What is the Face Value of Vinyl Chemicals (I) Ltd?
The Face Value of Vinyl Chemicals (I) Ltd is 1.00.